|
PANK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.48849829631581E-11 |
| Normal-vs-Stage2 |
3.000000E-02 |
| Normal-vs-Stage3 |
6.63669119660426E-12 |
| Normal-vs-Stage4 |
5.48269984967931E-10 |
| Stage1-vs-Stage2 |
4.457700E-03 |
| Stage1-vs-Stage3 |
8.984800E-01 |
| Stage1-vs-Stage4 |
5.856600E-01 |
| Stage2-vs-Stage3 |
7.882200E-03 |
| Stage2-vs-Stage4 |
4.641000E-03 |
| Stage3-vs-Stage4 |
6.095000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.82509571292167E-11 |
| Normal-vs-AfricanAmerican |
1.004910E-04 |
| Normal-vs-Asian |
2.24170000340251E-08 |
| Caucasian-vs-AfricanAmerican |
2.493400E-01 |
| Caucasian-vs-Asian |
8.218400E-01 |
| AfricanAmerican-vs-Asian |
3.340800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.06084063545131E-12 |
| Normal-vs-Female |
1.71862524211974E-12 |
| Male-vs-Female |
2.456200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.38179467867872E-11 |
| Normal-vs-Age(41-60Yrs) |
5.8317017881393E-11 |
| Normal-vs-Age(61-80Yrs) |
9.77690000000253E-05 |
| Normal-vs-Age(81-100Yrs) |
2.81169999949427E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.320400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.236500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.517200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.519800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.904220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.097500E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.826800E-01 |
| Classical-VS-Follicular |
2.596800E-04 |
| Classical-VS-Other |
6.261200E-01 |
| Classical-VS-Normal |
1.88909998755094E-11 |
| Tall-VS-Follicular |
1.228380E-04 |
| Tall-VS-Other |
9.022000E-01 |
| Tall-VS-Normal |
1.42259537483369E-11 |
| Follicular-VS-Other |
1.474220E-01 |
| Follicular-VS-Normal |
1.138350E-03 |
| Other-VS-Normal |
1.016690E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.87809792559801E-11 |
| Normal-vs-N1 |
1.6304735339645E-12 |
| N0-vs-N1 |
1.71849999996976E-06 |
|
|
